PB College Seminars Series
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2000) 24: 113-115. doi: 10.1192/pb.24.3.113
© 2000 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paton, C.
Right arrow Articles by Whitmore, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Paton, C.
Right arrow Articles by Whitmore, J.
Psychiatric Bulletin (2000) 24: 113-115
© 2000 The Royal College of Psychiatrists


Drug information quarterly

Benzodiazepines in schizophrenia. Is there a trend towards long-term prescribing?

Carol Paton, Principal Pharmacist and Stuart Banham, Clinical Pharmacist

Oxleas NHS Trust, Bexley Hospital, Old Bexley Lane, Bexley, Kent DA5 2BW

John Whitmore, Principal Pharmacist

Stone House Hospital, Dartford, Kent

AIMS AND METHOD

We sought to determine the prevalence of long-term benzodiazepine prescribing in patients with schizophrenia occupying psychiatric rehabilitation beds. A cross-sectional survey was conducted in 11 National Health Service trusts.

RESULTS

Almost 10% of patients occupying rehabilitation beds had a diagnosis of schizophrenia and received long-term benzodiazepines in combination with one or more antipsychotics.

CLINICAL IMPLICATIONS

Our results are consistent with those of other authors and show that benzodiazepines are frequently used in the long-term in patients with schizophrenia despite a lack of open acknowledgement of this practice and a paucity of objective data to support its efficacy.




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
C. Haw and J. Stubbs
Benzodiazepines a necessary evil? A survey of prescribing at a specialist UK psychiatric hospital
J Psychopharmacol, August 1, 2007; 21(6): 645 - 649.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2000 The Royal College of Psychiatrists.